Related Experiment Video
Updated: Nov 3, 2025

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
Published on: March 21, 2021
Association between baseline Controlling Nutritional Status score and clinical outcomes of patients with multiple
Xin Zhou1,1, Yan Lu1,2,1, Jun Xia1
1Department of Hematology, Wuxi People's Hospital, Nanjing Medical University, Wuxi, Jiangsu, China.
Background:
The Controlling Nutritional Status (CONUT) score, a novel immuno-nutritional index, was reported as a predictor of overall survival (OS) in some tumors.
Objective:
We aimed to investigate the association between baseline CONUT Score and clinical outcomes in patients with multiple myeloma (MM).
Methods:
We performed a retrospective analysis of 245 patients with MM. The CONUT score was determined prior to therapy.
Results:
Among the entire cohort, the complete remission rate was markedly higher in the low-CONUT (⩽ 3) group compared to the mid-CONUT (4-9) group or high-CONUT (> 9) group (44.1% vs 25.8%, P= 0.039; 44.1% vs 12.5%, P= 0.002). Patients with CONUT score > 9 had significant poor prognosis, and CONUT score ⩽ 3 group showed better survival outcome than other groups in OS (P< 0.001). Besides, we stratified the patients by combining International Staging System (ISS) stage and CONUT score in a model, and found that CONUT score could improve the prognostic impact of ISS stages on OS. In multivariate analysis, older age (⩾ 70 years) and a high CONUT score (⩾ 4) were independent prognostic risk factors for OS.
Conclusions:
The CONUT score was a predictor of OS in MM patients especially in cases with both low ISS staging and CONUT score. The baseline CONUT score may be an early and practical indicator of the efficacy of anti-myeloma treatment.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Chronic Kidney Disease III: Interprofessional Care
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Bioavailability Study Design: Healthy Subjects Versus Patients
Cancer Survival Analysis
Comparing the Survival Analysis of Two or More Groups

